arginine vasopressin

Vasopressin (argipressin) 是一种由下丘脑神经元合成的环状九肽，是肽原激素合成中的一种激素。Vasopressin 参与下丘脑-垂体-肾上腺轴调节过程，增加无溶质水从肾小管的滤液中重新吸收回循环中的量，收缩小动脉提高压强，增强促肾上腺皮质激素释放因子的刺激作用调节垂体促肾上腺皮质激素分泌。Vasopressin 在神经传导过程中可作为神经递质，与特定的 G 蛋白偶联受体结合发挥作用。

[Deamino-4-valine, 8-D-arginine]-Vasopressin (dVDAVP)为一种抗利尿药，具有高效性、特异性以及延长的药效特点。

Desmopressin acetate is a synthetic replacement for vasopressin, which reduces urine production. Medical use of Desmopressin acetate includes: (a) bed wetting; (b) diabetes insipidus; (c) nighttime urination; (d) clotting disorders.

Tolvaptan (OPC-41061) 是一种可口服的选择性精氨酸加压素受体 2 拮抗剂，可用于治疗低钠血症。

Desmopressin acetate (16679-58-6 free base) (DDAVP) 是抗利尿激素精氨酸加压素的合成类似物。

Fuscoside (OPC-21268) 是一种非肽精氨酸加压素 (AVP) 受体 VI 拮抗剂，IC50值为0.4 μM[2]。

Pneumadin, rat (PNM) exerts a marked antidiuretic effect in animals has a functional AVP system. Pneumadin, rat (PNM) is a decapeptide, which possesses a potent stimulating effect on arginine-vasopressin (AVP) release.

Felypressin acetate (PLV-2) 是加压素 1 的激动剂，作用于所有精氨酸加压素受体 1AS。 Felypressin acetate 可用于牙科手术。

YM 471 is a non-peptide arginine vasopressin (AVP) V1A and V2 receptor antagonist with oral activity.

YM-430 is a β1 adrenergic receptor antagonist and a calcium channel antagonist. YM430 could be both an antianginal and antihypertensive agent. YM430 (10(-8)-10(-6) M) inhibited 3,4-diaminopyridine-induced rhythmic contractions with an IC50 value of 59.2 n

SKF 100398, also known as d(CH2)5Tyr(Et)VAVP, is a particular analog of arginine vasopressin (AVP). It acts as a specific antagonist, specifically targeting the antidiuretic effect caused by both exogenous and endogenous AVP.

Mozavaptan (OPC-31260) 是 benzazepine 衍生物，是一种竞争性加压素受体拮抗剂，作用于 V1 和 V2 受体，IC50 分别为 1.2 μM 和 14 nM。它可在体内拮抗精氨酸加压素的抗利尿作用，可用于低钠血症、抗利尿激素不适当综合征和充血性心力衰竭的研究。

JTP-4819 is a potent and selective prolyl endopeptidase (PEP) inhibitor with potential for treating Alzheimer's disease. At nanomolar concentration, JTP-4819 inhibited the degradation of substance P, arginine-vasopressin, and thyrotropin-releasing hormone by PEP in supernatants of the rat cerebral cortex and hippocampus. Repeated administration of JTP-4819 reversed the aging-induced decrease in brain substance P-like and thyrotropin-releasing hormone-like immunoreactivity, suggesting that this drug may be able to improve the imbalance of peptidergic neuronal systems that develops with senescense by inhibiting PEP activity. JTP-4819 increased acetylcholine release from the frontal cortex and hippocampus, regions closely associated with memory, in both young and aged rats.

Vasopressin acetate (113-79-1(free base)) 是一种具有血管收缩和抗利尿活性的肽激素，可与血管精氨酸加压素受体 V1 结合，在 A7r5 大鼠主动脉平滑肌细胞和新生大鼠心肌细胞中的 Kd 值分别为 1.31 和 1.44 nM。

[8-L-arginine] deaminovasopressin (dAVP) 是一种抗利尿激素类似物。

Dp[Tyr(methyl)2,Arg8]-Vasopressin 是一种作用于肽精氨酸加压素 V1b 受体的非选择性拮抗剂。

[Pmp1,Tyr(OEt)2] AVP为环状加压素(AVP)的线性拮抗剂，具备相似结构。

[Deamino-Pen1,Val4,D-Arg8]-vasopressin (AVP-A)是一种作用于精氨酸血管加压素(AVP)的拮抗剂，它能有效地降低大鼠血浆中的醛固酮浓度。本化合物主要应用于研究大鼠肾上腺球状带的生长及其类固醇生成作用。

Peptide pva, encoded by an RNA, is complementary to arginine vasopressin mRNA.

Salusin-β是一种内源性生物活性肽,具备血流动力学效应和促进有丝分裂的功能.它能激活静止状态的血管平滑肌细胞(VSMCs)和成纤维细胞,从而迅速而显著地降低血压和心率.同时,在大鼠实验中,Salusin-β可促进垂体分泌精氨酸加压素,显示出其在心血管疾病研究领域的广泛应用前景.